{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:16:30Z","timestamp":1790356590454,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T00:00:00Z","timestamp":1758931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T00:00:00Z","timestamp":1758931200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009857","name":"Regeneron Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009857","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s12325-025-03378-2","type":"journal-article","created":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T07:16:46Z","timestamp":1758957406000},"page":"5980-5993","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Peak Nasal Inspiratory Flow and the Association with Nasal Obstruction in Patients with Severe CRSwNP from the SINUS-24\/-52 Studies"],"prefix":"10.1007","volume":"42","author":[{"given":"Martin","family":"Desrosiers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Nash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Lane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella E.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"De Corso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changming","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Corbett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr","family":"Radwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yamo","family":"Deniz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,27]]},"reference":[{"issue":"5","key":"3378_CR1","first-page":"343","volume":"57","author":"A Khan","year":"2019","unstructured":"Khan A, Huynh TMT, Vandeplas G, et al. The GALEN rhinosinusitis cohort: chronic rhinosinusitis with nasal polyps affects health-related quality of life. Rhinology. 2019;57(5):343\u201351.","journal-title":"Rhinology"},{"key":"3378_CR2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2147\/JAA.S290424","volume":"14","author":"C Bachert","year":"2021","unstructured":"Bachert C, Bhattacharyya N, Desrosiers M, Khan AH. Burden of disease in chronic rhinosinusitis with nasal polyps. J Asthma Allergy. 2021;14:127\u201334.","journal-title":"J Asthma Allergy"},{"issue":"4","key":"3378_CR3","doi-asserted-by":"publisher","first-page":"289","DOI":"10.4193\/Rhin.52E4","volume":"52","author":"WJ Fokkens","year":"2014","unstructured":"Fokkens WJ, Hellings PW. Objective measurements of nasal function: necessary before nasal surgery? Rhinology. 2014;52(4):289\u201391.","journal-title":"Rhinology"},{"issue":"4","key":"3378_CR4","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1111\/coa.13329","volume":"44","author":"G Ottaviano","year":"2019","unstructured":"Ottaviano G, Pendolino AL, Nardello E, et al. Peak nasal inspiratory flow measurement and visual analogue scale in a large adult population. Clin Otolaryngol. 2019;44(4):541\u20138.","journal-title":"Clin Otolaryngol"},{"issue":"4","key":"3378_CR5","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1097\/MLG.0b013e318161e56b","volume":"118","author":"C Berm\u00fcller","year":"2008","unstructured":"Berm\u00fcller C, Kirsche H, Rettinger G, Riechelmann H. Diagnostic accuracy of peak nasal inspiratory flow and rhinomanometry in functional rhinosurgery. Laryngoscope. 2008;118(4):605\u201310.","journal-title":"Laryngoscope"},{"issue":"1","key":"3378_CR6","first-page":"32","volume":"44","author":"G Ottaviano","year":"2006","unstructured":"Ottaviano G, Scadding GK, Coles S, Lund VJ. Peak nasal inspiratory flow; normal range in adult population. Rhinology. 2006;44(1):32\u20135.","journal-title":"Rhinology"},{"issue":"4","key":"3378_CR7","first-page":"206","volume":"41","author":"K Blomgren","year":"2003","unstructured":"Blomgren K, Simola M, Hyt\u00f6nen M, Pitk\u00e4ranta A. Peak nasal inspiratory and expiratory flow measurements\u2013practical tools in primary care? Rhinology. 2003;41(4):206\u201310.","journal-title":"Rhinology"},{"issue":"6","key":"3378_CR8","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1017\/S0022215111000181","volume":"125","author":"MD Bouzgarou","year":"2011","unstructured":"Bouzgarou MD, Ben Saad H, Chouchane A, et al. North African reference equation for peak nasal inspiratory flow. J Laryngol Otol. 2011;125(6):595\u2013602.","journal-title":"J Laryngol Otol"},{"issue":"4","key":"3378_CR9","first-page":"389","volume":"47","author":"JM Klossek","year":"2009","unstructured":"Klossek JM, Lebreton JP, Delagranda A, Dufour X. PNIF measurement in a healthy French population. A prospective study about 234 patients. Rhinology. 2009;47(4):389\u201392.","journal-title":"Rhinology"},{"issue":"9","key":"3378_CR10","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.3390\/jpm12091513","volume":"19","author":"G Ottaviano","year":"2022","unstructured":"Ottaviano G, Pendolino AL, Scarpa B, et al. Correlations between peak nasal inspiratory flow, acoustic rhinometry, 4-phase rhinomanometry and reported nasal symptoms. J Pers Med. 2022;19(9):1513.","journal-title":"J Pers Med"},{"issue":"1","key":"3378_CR11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nrd4624","volume":"15","author":"NA Gandhi","year":"2016","unstructured":"Gandhi NA, Bennett BL, Graham NM, Pirozzi G, Stahl N, Yancopoulos GD. Targeting key proximal drivers of type\u00a02 inflammation in disease. Nat Rev Drug Discov. 2016;15(1):35\u201350.","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"3378_CR12","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.anai.2019.12.001","volume":"124","author":"TM Laidlaw","year":"2020","unstructured":"Laidlaw TM, Buchheit KM. Biologics in chronic rhinosinusitis with nasal polyposis. Ann Allergy Asthma Immunol. 2020;124(4):326\u201332.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"3378_CR13","doi-asserted-by":"publisher","first-page":"354","DOI":"10.2500\/ajra.2013.27.3922","volume":"27","author":"M Katotomichelakis","year":"2013","unstructured":"Katotomichelakis M, Tantilipikorn P, Holtappels G, et al. Inflammatory patterns in upper airway disease in the same geographical area may change over time. Am J Rhinol Allergy. 2013;27(5):354\u201360.","journal-title":"Am J Rhinol Allergy"},{"issue":"3","key":"3378_CR14","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1177\/0194599813495363","volume":"149","author":"SJ Kim","year":"2013","unstructured":"Kim SJ, Lee KH, Kim SW, Cho JS, Park YK, Shin SY. Changes in histological features of nasal polyps in a Korean population over a 17-year period. Otolaryngol Head Neck Surg. 2013;149(3):431\u20137.","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"9","key":"3378_CR15","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1002\/alr.23150","volume":"13","author":"R Pezato","year":"2023","unstructured":"Pezato R, Stamm AC, Douglas R, et al. Nasal disease with polyps: need for clarity. Int Forum Allergy Rhinol. 2023;13(9):1829\u201331.","journal-title":"Int Forum Allergy Rhinol"},{"issue":"4","key":"3378_CR16","doi-asserted-by":"publisher","first-page":"386","DOI":"10.4193\/Rhino.12.071","volume":"50","author":"G Ottaviano","year":"2012","unstructured":"Ottaviano G, Scadding GK, Scarpa B, Accordi D, Staffieri A, Lund VJ. Unilateral peak nasal inspiratory flow, normal values in adult population. Rhinology. 2012;50(4):386\u201392.","journal-title":"Rhinology"},{"issue":"14","key":"3378_CR17","doi-asserted-by":"publisher","first-page":"5147","DOI":"10.1073\/pnas.1323896111","volume":"111","author":"LE Macdonald","year":"2014","unstructured":"Macdonald LE, Karow M, Stevens S, et al. Precise and in situ genetic humanization of 6 Mb of mouse immunoglobulin genes. Proc Natl Acad Sci U S A. 2014;111(14):5147\u201352.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"14","key":"3378_CR18","doi-asserted-by":"publisher","first-page":"5153","DOI":"10.1073\/pnas.1324022111","volume":"111","author":"AJ Murphy","year":"2014","unstructured":"Murphy AJ, Macdonald LE, Stevens S, et al. Mice with megabase humanization of their immunoglobulin genes generate antibodies as efficiently as normal mice. Proc Natl Acad Sci U S A. 2014;111(14):5153\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"3378_CR19","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1111\/all.14151","volume":"75","author":"A Le Floc'h","year":"2020","unstructured":"Le Floc\u2019h A, Allinne J, Nagashima K, et al. Dual blockade of IL-4 and IL-13 with dupilumab, an IL-4R\u03b1 antibody, is required to broadly inhibit type\u00a02 inflammation. Allergy. 2020;75(5):1188\u2013204.","journal-title":"Allergy"},{"issue":"10209","key":"3378_CR20","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1016\/S0140-6736(19)31881-1","volume":"394","author":"C Bachert","year":"2019","unstructured":"Bachert C, Han JK, Desrosiers M, et al. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase\u00a03 trials. Lancet. 2019;394(10209):1638\u201350.","journal-title":"Lancet"},{"key":"3378_CR21","doi-asserted-by":"publisher","first-page":"557","DOI":"10.2147\/JAA.S355391","volume":"15","author":"C Bachert","year":"2022","unstructured":"Bachert C, Khan AH, Hopkins C, et al. Rapid and continuing improvements in nasal symptoms with dupilumab in patients with severe CRSwNP. J Asthma Allergy. 2022;15:557\u201363.","journal-title":"J Asthma Allergy"},{"issue":"1","key":"3378_CR22","doi-asserted-by":"publisher","first-page":"37","DOI":"10.4193\/Rhino10.097","volume":"49","author":"D Timperley","year":"2011","unstructured":"Timperley D, Srubisky A, Stow N, Marcells GN, Harvey RJ. Minimal clinically important differences in nasal peak inspiratory flow. Rhinology. 2011;49(1):37\u201340.","journal-title":"Rhinology"},{"issue":"6","key":"3378_CR23","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/j.jaip.2022.03.002","volume":"10","author":"J Mullol","year":"2022","unstructured":"Mullol J, Azar A, Buchheit KM, Hopkins C, Bernstein JA. Chronic rhinosinusitis with nasal polyps: quality of life in the biologics era. J Allergy Clin Immunol Pract. 2022;10(6):1434\u201353.e9.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"3378_CR24","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1002\/lary.27566","volume":"129","author":"JC Fuller","year":"2019","unstructured":"Fuller JC, Gadkaree SK, Levesque PA, Lindsay RW. Peak nasal inspiratory flow is a useful measure of nasal airflow in functional septorhinoplasty. Laryngoscope. 2019;129(3):594\u2013601.","journal-title":"Laryngoscope"},{"issue":"4","key":"3378_CR25","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1159\/000027595","volume":"60","author":"A Hirschberg","year":"1998","unstructured":"Hirschberg A, Rezek \u00d6. Correlation between objective and subjective assessments of nasal patency. ORL J Otorhinolaryngol Relat Spec. 1998;60(4):206\u201311.","journal-title":"ORL J Otorhinolaryngol Relat Spec"}],"updated-by":[{"DOI":"10.1007\/s12325-025-03444-9","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000}}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-025-03378-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-025-03378-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-025-03378-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T06:38:58Z","timestamp":1766558338000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-025-03378-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,27]]},"references-count":25,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["3378"],"URL":"https:\/\/doi.org\/10.1007\/s12325-025-03378-2","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,27]]},"assertion":[{"value":"12 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s12325-025-03444-9","URL":"https:\/\/doi.org\/10.1007\/s12325-025-03444-9","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Martin Desrosiers reports clinical trial funding from AstraZeneca, GSK, Probionase Therapies, and Sanofi, is a stock shareholder in Probionase Therapies, and is an advisory board member\/consultant for Regeneron Pharmaceuticals Inc. Andrew Lane is an advisory board member for Regeneron Pharmaceuticals Inc. and Sanofi. Stella E. Lee is an advisory board member for and reports clinical trial finding from AstraZeneca, Genentech, GSK, Regeneron Pharmaceuticals Inc., and Sanofi, and reports publication support from AstraZeneca, GSK, Regeneron Pharmaceuticals Inc., and Sanofi. Eugenio De Corso is an advisory board member\/consultant for and reports clinical trial funding and publication support from AstraZeneca, GSK, Novartis, and Sanofi. Scott Nash, Changming Xia, Amr Radwan, and Yamo Deniz are employees of Regeneron Pharmaceuticals Inc. and may hold stock and\/or stock options in the company. Mark Corbett and Paul J. Rowe are employees of Sanofi and may hold stock and\/or stock options in the company.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The SINUS-24 and SINUS-52 studies were conducted according to the principles laid down in the Declaration of Helsinki. Institutional review boards and independent ethics committees reviewed and approved the protocols, informed consent forms, and patient information before study initiation. A full list is available in the supplementary materials.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}